Sonnet Biotherapeutics HoldiSONN
13F holders, Q4 2024 (December 31)9holders +7
7new positions
1sold out
1famous investor
$1.46avg. 13F price*
At the end of Q4 2024, 9 institutions reported holding Sonnet Biotherapeutics Holdi (SONN) in their 13F filings, up 7 from Q3 2024. 7 opened new positions and 1 sold out. The largest holders were Virtu Financial LLC ($58K), Citadel Advisors ($35K) and Two Sigma Investments, LP ($28K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Sonnet Biotherapeutics Holdi
- CUSIP
- 83548R402
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $121K |
| Exits | 1 | $3 |
All 13F filers, Q3 2024 → Q4 2024: 88,627 shares bought, net +88,627 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 9 holders
| Virtu Financial LLC | 0.00% | New | 39,647 | $58K |
| Citadel Advisors | 0.00% | New | 24,013 | $35K |
| Two Sigma Investments, LP | 0.00% | New | 19,203 | $28K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +1513.8% | 6,100 | $9K |
| BlackRock, Inc. | 0.00% | No change | 65 | $95 |
| Carolina Wealth Advisors, LLC | 0.00% | New | 32 | $47 |
| Bank of America Corp. | 0.00% | New | 5 | $7 |
| UBS Group AG | 0.00% | New | 3 | $4 |
| Citigroup Inc. | 0.00% | New | 2 | $3 |
"% of holder's portfolio" is SONN's weight in each manager's 13F, not the share of Sonnet Biotherapeutics Holdi the manager owns.